Last verified: May 2026
The 17 Qualifying Conditions
| 17 Qualifying Conditions Under O.C.G.A. § 16-12-191 (May 2026) | |
|---|---|
| 1. Cancer (end-stage; or treatment causes wasting/recalcitrant N&V) | 2. ALS (severe or end-stage) |
| 3. Seizure disorders (epilepsy or trauma-related) | 4. Multiple sclerosis (severe or end-stage) |
| 5. Crohn’s disease | 6. Mitochondrial disease |
| 7. Parkinson’s disease (severe or end-stage) | 8. Sickle cell disease (severe or end-stage) |
| 9. Tourette’s syndrome (severe) | 10. Autism spectrum disorder (18+; minors only with severe diagnosis) |
| 11. Epidermolysis bullosa | 12. Alzheimer’s disease (severe or end-stage) |
| 13. AIDS (severe or end-stage) | 14. Peripheral neuropathy (severe or end-stage) |
| 15. Hospice patient | 16. Intractable pain (added by HB 65, 2018) |
| 17. Post-traumatic stress disorder (added by HB 65, 2018; refined to require direct trauma exposure for adults 18+) | |
Source: O.C.G.A. § 16-12-191 (Haleigh’s Hope Act qualifying conditions list as expanded by SB 16 of 2017 and HB 65 of 2018). ⚠️ SB 220 (2026), pending Gov. Kemp’s signature with a ~May 12, 2026 deadline, would expand the list to add lupus, severe arthritis, and severe insomnia and would remove the "severe or end-stage" qualifier from cancer, MS, Parkinson’s, Alzheimer’s, and other conditions.
How the List Was Built
The original Haleigh’s Hope Act (HB 1, 2015) listed 8 qualifying conditions:
- Cancer (end-stage; or treatment causes wasting/recalcitrant N&V).
- ALS (severe or end-stage).
- Seizure disorders (epilepsy or trauma-related).
- Multiple sclerosis (severe or end-stage).
- Crohn’s disease.
- Mitochondrial disease.
- Parkinson’s disease (severe or end-stage).
- Sickle cell disease (severe or end-stage).
Sen. Renee Unterman’s removal of fibromyalgia in committee was widely critiqued at the time but ultimately stuck.
SB 16 (2017) — Six Conditions Added
- Tourette’s syndrome (severe).
- Autism spectrum disorder.
- Epidermolysis bullosa.
- Alzheimer’s disease (severe or end-stage).
- AIDS (severe or end-stage).
- Peripheral neuropathy (severe or end-stage).
HB 65 (2018) — Three Conditions Added
- Patient in hospice program.
- Intractable pain.
- Post-traumatic stress disorder (PTSD).
HB 65’s addition of intractable pain and PTSD transformed the registry composition. The original list focused on severe pediatric and end-stage conditions; the additions opened the program to a far broader adult patient population. As of late 2025, more than 75% of registrants cite either intractable pain or PTSD as their qualifying condition.
The "Severe or End-Stage" Problem
Many of the named conditions carry the qualifier "severe or end-stage" — a clinical hurdle that can exclude patients with documented diagnoses but moderate disease progression. SB 220 (2026), pending Gov. Kemp’s signature with a ~May 12, 2026 deadline, would remove this qualifier from many conditions including cancer, MS, Parkinson’s, and Alzheimer’s — substantially expanding patient eligibility within the existing diagnostic categories.
Three Conditions SB 220 (2026) Would Add
If Gov. Kemp signs SB 220 by ~May 12, 2026, the list would expand to add:
- Lupus.
- Severe arthritis.
- Severe insomnia.
These additions would meaningfully broaden patient access for the autoimmune-disease population (lupus, severe arthritis) and for the substantial population of adult patients using cannabis off-label for sleep. See SB 220 page.
The PTSD Pathway
HB 65 added PTSD in 2018 with a refinement in subsequent rule-making: PTSD certification for adults 18+ requires direct trauma exposure — combat experience, first-responder duty, sexual assault, severe accident, etc. Indirect-trauma PTSD (e.g., professional secondary trauma in mental-health workers) generally does not qualify. The PTSD pathway is one of the highest-volume certifications in the program; veterans communities particularly drive PTSD-pathway registrations.
Autism — Adult and Pediatric
Georgia is one of the more permissive medical-cannabis programs on autism: adults with autism spectrum disorder qualify (the only general-population pathway not requiring "severe" or "end-stage" status). Minor patients with autism qualify only if the diagnosis is severe. Parental-caregiver registration is required for any minor patient.
How Patients Document a Qualifying Condition
- Cancer. Oncologist treatment records demonstrating end-stage disease or wasting/N&V from chemotherapy.
- ALS, Multiple Sclerosis, Parkinson’s, Alzheimer’s, Sickle Cell. Treating-specialist records documenting diagnosis and severity. SB 220 would relax "severe or end-stage" requirements.
- Seizure disorders. Neurologist records, EEG findings.
- Crohn’s, Tourette’s, Epidermolysis Bullosa, AIDS, Peripheral Neuropathy, Mitochondrial Disease. Specialist records of confirmed diagnosis.
- Autism (adult). Documentation of formal autism-spectrum-disorder diagnosis from psychologist, psychiatrist, or developmental specialist.
- Hospice patient. Documentation of hospice enrollment.
- Intractable pain. Documented chronic-pain diagnosis with prior failed conventional treatment regimens.
- PTSD. Formal PTSD diagnosis with documentation of direct trauma exposure (for adults 18+).
Practical Guidance for Prospective Patients
- Match your documented diagnosis to one of the 17 specific pathways before the practitioner visit.
- Bring treating-provider records, prior diagnostic imaging or lab work, prior treatment history, and any specialist consultations.
- If your condition isn’t on the list (e.g., generalized anxiety, ADHD, depression alone, fibromyalgia), the practitioner cannot certify. Consider whether one of the pathway diagnoses applies.
- For minor patients, parental consent + parental-caregiver application is required.
- Watch SB 220 closely — if signed, it expands access materially.
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org